Basic net loss per share is calculated utilizing the weighted average number of common shares outstanding during the periods presented. Diluted net loss per share is calculated utilizing the weighted average number of common shares outstanding during the periods presented adjusted for the effect of dilutive common stock equivalents.

The following table sets forth the computation of basic and diluted net loss per share data:


	Three Months Ended
	April 1,			April 2,
	2023			2022
Numerator:
Net loss	$	(118,679	)	$	(8,243	)
Denominator:
Weighted average shares of common stock outstanding		70,596			70,086
Effect of dilutive common stock equivalents		—			—
Weighted average diluted common shares outstanding		70,596			70,086
Net loss per share
Basic	$	(1.68	)	$	(0.12	)
Diluted	$	(1.68	)	$	(0.12	)

See Note 17 for details on the newly issued shares of the Company’s common stock upon the completion of its acquisition of Sequence (as defined below).

The number of anti-dilutive common stock equivalents excluded from the calculation of the weighted average number of common shares for diluted net loss per share was 8,999 and 7,040 for the three months ended April 1, 2023 and April 2, 2022, respectively.